RC 1 - Product
How can we exploit 3D printing and advanced polymers to create smart 21st Century products ready for use across multiple sectors?
Leading team: Felicity Rose (Lead), and Wayne Hayes (Co-Lead)
AIM: Transformative future products to drive development of our manufacturing toolkit. Exploiting our strong industry and clinical connectivity within the pharmaceutical, regenerative medicine and biocatalysis fields, we will develop next-generation products to drive highly efficacious and targeted solutions that can only be realised through the geometrical and compositional freedoms offered by 3D printing (3DP).
These exemplars include:
- Solid dosage forms (tablets) for oral delivery of biotherapeutics
- An intestinal patch that can rebuild tissues damaged through chronic disease
- Biocatalytic flow reactors requiring precision enzyme immobilisation for process intensification.
These advanced products have strong transformational potential within their respective fields but are not currently manufacturable due to lack of materials, design and process, thereby epitomizing the challenges that need to be solved
Investigators Team: Felicity Rose (Lead), Wayne Hayes (Co-Lead), Clive Roberts, Cameron Alexander, Anca Pordea, Derek Irvine, Ricky Wildman, and Roisin Owens
Nottingham Research fellowships: Robert Owen
Research Fellows: Valentina Cuzzucoli Crucitti, Keyvan Jodeiri, Silvia Santoni and Nathan Carpentier
PhD Students: Charles Heaton and William Pritchard